Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Lessons learned and new horizons and other hepatobiliary/pancreatic malignancies

The role of immunotherapy and other targeted treatments

Date

10 Sep 2022

Session

Lessons learned and new horizons and other hepatobiliary/pancreatic malignancies

Topics

Molecular Oncology

Tumour Site

Hepatobiliary Cancers;  Pancreatic Adenocarcinoma

Presenters

Arndt Vogel

Authors

A. Vogel

Author affiliations

  • Gastro/hepato And Endocrinology Department, MHH - Medizinische Hochschule Hannover, 30625 - Hannover/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.